Sandbox:Reddy: Difference between revisions

Jump to navigation Jump to search
(Blanked the page)
No edit summary
Line 1: Line 1:
OUT Patient
{| class="wikitable"
|'''Dysenteric Diarrhea'''
Frequent, sometimes bloody, small-volume diarrhea associated with abdominal pain and cramping.


Patient may be febrile and toxic.
|''Shigella''
''Salmonella''
''Campylobacter''
''Yersinia''
''E. coli'' 0157:H7
''''C.difficile'''' 
|'''Ciprofloxacin''' 500 mg PO BID
OR
'''Ciprofloxacin''' 750 mg daily x 3 days
(avoid in cases of ''E. coli'' O157:H7 as it may increase the risk of hemolytic-uremic syndrome)
Recent antibiotic exposure: consider ''C. difficile''
Antimotility drugs should not be used in ''C.difficile.''
''C. difficile -'' '''Metronidazole''' 500 mg PO TID x 10-14 days. If no response at 5 days, switch to '''Vancomycin''' 125mg PO QID x10-14 days. See inpatient guidelines for severe or recurrent ''C. difficile'' infection and/or policy on ''C. difficile'' management.
|
* '''Empiric therapy''' is generally indicated if patient is toxic appearing, elderly or immunocompromised.  If empiric therapy is given, obtain culture and give fluoroquinolone x 3 days while awaiting cultures
* '''Azithromycin''' should be used for pregnancy and suspected quinolone resistant ''Campylobacter.''
* Antimotility drugs improve symptoms and can be used if patient is not toxic.  
* Antimicrobial treatment may worsen outcomes in patients with ''E. coli''0157:H7
* ''E. histolytica'' - '''Metronidazole''' 750 mg PO TID x 7-10 days then '''Iodoquinol''' 650 mg PO TID x 20 days or '''Paromomycin'''5 25-35 mg/kg/day in 3 divided doses x 7 days
|-
|'''Nondysenteric Diarrhea'''
Large volume, nonbloody, watery diarrhea.
Patient may have nausea, vomiting, and abdominal cramping but fever often absent.
|Viruses
''Giardia''
Enterotoxigenic ''E. coli''
''Enterotoxin-producing bacteria''
|General Care: Observation
Oral rehydration
Antimotility agents
''Giardia –'' especially if patient describes recent history of travel and/or ingestion of unfiltered water (e.g., camping), consider – '''Metronidazole''' 250 mg PO TID x 5 days.
|
* Generally, empiric therapy and stool cultures are '''not''' indicated. Most disease is self-limiting and can be treated with antimotility agents
* If patient fails to improve, cultures (-), and symptoms persist, consider stool for O & P.
* Metronidazole resistance seen in 20% giardia cases.  Check ''C. difficile'' toxin if recent history of antibiotic use or hospitalization.
|-
|'''Traveler’s diarrhea'''
Empiric treatment while abroad
|Toxigenic ''E. coli''
''Salmonella''
''Shigella''
''Campylobacter''
Amebiasis
|'''Ciprofloxacin''' 500 mg PO BID x 1-3 days
Pregnancy or fluoroquinolone-resistant campylobacter:
'''Azithromycin''' 1 g x 1 dose
EITHER WITH or WITHOUT:
'''Loperamide''' 4 mg PO x 1; then 2 mg after each loose stool,
MAX 16 mg/day
|Mild, self-limited cases can be treated with fluid and electrolyte repletion and bismuth subsalicylate.
Prophylaxis generally not recommended.
|}

Revision as of 19:50, 29 June 2017

OUT Patient

Dysenteric Diarrhea

Frequent, sometimes bloody, small-volume diarrhea associated with abdominal pain and cramping.

Patient may be febrile and toxic.

Shigella

Salmonella

Campylobacter

Yersinia

E. coli 0157:H7

'C.difficile' 

Ciprofloxacin 500 mg PO BID

OR

Ciprofloxacin 750 mg daily x 3 days

(avoid in cases of E. coli O157:H7 as it may increase the risk of hemolytic-uremic syndrome)

Recent antibiotic exposure: consider C. difficile

Antimotility drugs should not be used in C.difficile.

C. difficile - Metronidazole 500 mg PO TID x 10-14 days. If no response at 5 days, switch to Vancomycin 125mg PO QID x10-14 days. See inpatient guidelines for severe or recurrent C. difficile infection and/or policy on C. difficile management.

  • Empiric therapy is generally indicated if patient is toxic appearing, elderly or immunocompromised.  If empiric therapy is given, obtain culture and give fluoroquinolone x 3 days while awaiting cultures
  • Azithromycin should be used for pregnancy and suspected quinolone resistant Campylobacter.
  • Antimotility drugs improve symptoms and can be used if patient is not toxic.  
  • Antimicrobial treatment may worsen outcomes in patients with E. coli0157:H7
  • E. histolytica - Metronidazole 750 mg PO TID x 7-10 days then Iodoquinol 650 mg PO TID x 20 days or Paromomycin5 25-35 mg/kg/day in 3 divided doses x 7 days
Nondysenteric Diarrhea

Large volume, nonbloody, watery diarrhea.

Patient may have nausea, vomiting, and abdominal cramping but fever often absent.

Viruses

Giardia

Enterotoxigenic E. coli

Enterotoxin-producing bacteria

General Care: Observation

Oral rehydration

Antimotility agents

Giardia – especially if patient describes recent history of travel and/or ingestion of unfiltered water (e.g., camping), consider – Metronidazole 250 mg PO TID x 5 days.

  • Generally, empiric therapy and stool cultures are not indicated. Most disease is self-limiting and can be treated with antimotility agents
  • If patient fails to improve, cultures (-), and symptoms persist, consider stool for O & P.
  • Metronidazole resistance seen in 20% giardia cases. Check C. difficile toxin if recent history of antibiotic use or hospitalization.
Traveler’s diarrhea

Empiric treatment while abroad

Toxigenic E. coli

Salmonella

Shigella

Campylobacter

Amebiasis

Ciprofloxacin 500 mg PO BID x 1-3 days

Pregnancy or fluoroquinolone-resistant campylobacter:

Azithromycin 1 g x 1 dose

EITHER WITH or WITHOUT:

Loperamide 4 mg PO x 1; then 2 mg after each loose stool,

MAX 16 mg/day

Mild, self-limited cases can be treated with fluid and electrolyte repletion and bismuth subsalicylate.

Prophylaxis generally not recommended.